Landi, N.; Ciaramella, V.; Ragucci, S.; Chambery, A.; Ciardiello, F.; Pedone, P.V.; Troiani, T.; Di Maro, A.
A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells. Toxins 2023, 15, 57.
https://doi.org/10.3390/toxins15010057
AMA Style
Landi N, Ciaramella V, Ragucci S, Chambery A, Ciardiello F, Pedone PV, Troiani T, Di Maro A.
A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells. Toxins. 2023; 15(1):57.
https://doi.org/10.3390/toxins15010057
Chicago/Turabian Style
Landi, Nicola, Vincenza Ciaramella, Sara Ragucci, Angela Chambery, Fortunato Ciardiello, Paolo V. Pedone, Teresa Troiani, and Antimo Di Maro.
2023. "A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells" Toxins 15, no. 1: 57.
https://doi.org/10.3390/toxins15010057
APA Style
Landi, N., Ciaramella, V., Ragucci, S., Chambery, A., Ciardiello, F., Pedone, P. V., Troiani, T., & Di Maro, A.
(2023). A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells. Toxins, 15(1), 57.
https://doi.org/10.3390/toxins15010057